請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62576
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 謝松蒼(Sung-Tsang Hsieh) | |
dc.contributor.author | Tsz-Yi Tang | en |
dc.contributor.author | 唐慈翊 | zh_TW |
dc.date.accessioned | 2021-06-16T16:04:48Z | - |
dc.date.available | 2018-09-24 | |
dc.date.copyright | 2013-09-24 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-06-25 | |
dc.identifier.citation | 參考文獻
Ambarus CA, Krausz S, van Eijk M, Hamann J, Radstake TR, Reedquist KA, Tak PP, Baeten DL (2012) Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. Journal of immunological methods 375:196-206. Andersson R (1970) Hereditary amyloidosis with polyneuropathy. Acta medica Scandinavica 1-2:85-94. Andersson R, Blom S (1972) Neurophysiological studies in hereditary amyloidosis with polyneuropathy. Acta medica Scandinavica 191:233-239. Ando E, Ando Y, Maruoka S, Sakai Y, Watanabe S, Yamashita R, Okamura R, Araki S (1992) Ocular microangiopathy in familial amyloidotic polyneuropathy, type I. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 230:1-5. Ando Y, Asahara K, Obayashi K, Suhr O, Yonemitsu M, Yamashita T, Tashima K, Uchino M, Ando M (1996) Autonomic dysfunction and anemia in neurologic disorders. Journal of the autonomic nervous system 61:145-148. Araki S (1984) Type I familial amyloidotic polyneuropathy (Japanese type). Brain & development 6:128-133. Asahara K, Ando Y, Tanaka Y, Yi S, Yamashita T, Ando M (1993) Secondary hypoplastic anemia in patients with familial amyloidotic polyneuropathy. Acta haematologica 90:130-135. Asahina M, Yoshiyama Y, Hattori T (2001) Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clinical neuropathology 20:60-63. Authier FJ, Lechapt-Zalcman E, Mussini JM, Plante-Bordeneuve V, Eizenbaum JF, Jacobson DR, Gherardi RK (1999) Marked systemic amyloid angiopathy in patients with val 107 transthyretin mutation. Journal of clinical neuromuscular disease 1:82-85. Biswas SK, Chittezhath M, Shalova IN, Lim JY (2012) Macrophage polarization and plasticity in health and disease. Immunologic research 53:11-24. Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nature immunology 11:889-896. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C, Galitzky J, Lafontan M, Karpe F, Frayn KN, Bouloumie A (2008) Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 117:806-815. Britland ST, Young RJ, Sharma AK, Clarke BF (1990) Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 39:909-913. Cassetta L, Cassol E, Poli G (2011) Macrophage polarization in health and disease. TheScientificWorldJournal 11:2391-2402. Dangaj D, Abbott KL, Mookerjee A, Zhao A, Kirby PS, Sandaltzopoulos R, Powell DJ, Jr., Lamaziere A, Siegel DL, Wolf C, Scholler N (2011) Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody. PloS one 6:e28386. Dangas G, Badimon JJ, Coller BS, Fallon JT, Sharma SK, Hayes RM, Meraj P, Ambrose JA, Marmur JD (1998) Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab. Arteriosclerosis, thrombosis, and vascular biology 18:1342-1349. Drake TA, Morrissey JH, Edgington TS (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. The American journal of pathology 134:1087-1097. Dyck PJ, Lambert EH (1969) Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. Archives of neurology 20:490-507. Edwards JP, Zhang X, Frauwirth KA, Mosser DM (2006) Biochemical and functional characterization of three activated macrophage populations. Journal of leukocyte biology 80:1298-1307. Eisenhauer PB, Johnson RJ, Wells JM, Davies TA, Fine RE (2000) Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: increased toxicity of dutch-type mutant. Journal of neuroscience research 60:804-810. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, Robertson EJ (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proceedings of the National Academy of Sciences of the United States of America 90:2375-2379. Esmon NL, Owen WG, Esmon CT (1982) Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. The Journal of biological chemistry 257:859-864. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. Journal of the American College of Cardiology 23:1562-1569. Fleury V, Loyau S, Lijnen HR, Nieuwenhuizen W, Angles-Cano E (1993) Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface. European journal of biochemistry / FEBS 216:549-556. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de Winther MP, Pasparakis M (2008) Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell metabolism 8:372-383. Gersuk G, Hiraoka A, Marr KA (2005) Human monocytes differentiate into macrophages under the influence of human KPB-M15 conditioned medium. Journal of immunological methods 299:99-106. Giannini C, Dyck PJ (1994) Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Annals of neurology 36:408-415. Goerdt S, Politz O, Schledzewski K, Birk R, Gratchev A, Guillot P, Hakiy N, Klemke CD, Dippel E, Kodelja V, Orfanos CE (1999) Alternative versus classical activation of macrophages. Pathobiology : journal of immunopathology, molecular and cellular biology 67:222-226. Hawkes CA, McLaurin J (2009) Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proceedings of the National Academy of Sciences of the United States of America 106:1261-1266. He LZ, Crocker A, Lee J, Mendoza-Ramirez J, Wang XT, Vitale LA, O'Neill T, Petromilli C, Zhang HF, Lopez J, Rohrer D, Keler T, Clynes R (2007) Antigenic targeting of the human mannose receptor induces tumor immunity. Journal of immunology 178:6259-6267. Hoffmeister HM (2001) [Overview of the relevant aspects of the blood coagulation system--focus and cardiovascular hemostasis]. Kongressband / Deutsche Gesellschaft fur Chirurgie Deutsche Gesellschaft fur Chirurgie Kongress 118:572-575. Horne M (2005) Overview of hemostasis and thrombosis; current status of antithrombotic therapies. Thrombosis research 117:15-17; discussion 39-42. Hultman K, Strickland S, Norris EH (2013) The APOE varepsilon4/varepsilon4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S (1998) Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain research Molecular brain research 57:1-9. Jackson SP (2011) Arterial thrombosis--insidious, unpredictable and deadly. Nature medicine 17:1423-1436. Jiang X, Smith CS, Petrassi HM, Hammarstrom P, White JT, Sacchettini JC, Kelly JW (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 40:11442-11452. Kawaji T, Ando Y, Nakamura M, Yamashita T, Wakita M, Ando E, Hirata A, Tanihara H (2005) Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C. Ophthalmology 112:2212. Kelly JW The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Current opinion in structural biology 8:101-106. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. The Journal of neuroscience : the official journal of the Society for Neuroscience 29:13435-13444. Kodelja V, Muller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S (1997) Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 197:478-493. Kondo Y, Adams JM, Vanier MT, Duncan ID (2011) Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy. The Journal of neuroscience : the official journal of the Society for Neuroscience 31:3610-3624. Kuijper PH, Gallardo Torres HI, Lammers JW, Sixma JJ, Koenderman L, Zwaginga JJ (1997) Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions. Blood 89:166-175. Labarrere CA, Woods JR, Hardin JW, Campana GL, Ortiz MA, Jaeger BR, Reichart B, Bonnin JM, Currin A, Cosgrove S, Pitts DE, Kirlin PC, O'Donnell JA, Hormuth DA, Wozniak TC (2011) Early prediction of cardiac allograft vasculopathy and heart transplant failure. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 11:528-535. Lai Z, Colon W, Kelly JW (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35:6470-6482. Larsen GR, Henson K, Blue Y (1988) Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domains. The Journal of biological chemistry 263:1023-1029. Ledesma MD, Da Silva JS, Crassaerts K, Delacourte A, De Strooper B, Dotti CG (2000) Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO reports 1:530-535. Levin EG, Marzec U, Anderson J, Harker LA (1984) Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. The Journal of clinical investigation 74:1988-1995. Levy J, Hawkins PN, Rowczenio D, Godfrey T, Stawell R, Zamir E (2012) Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 19:201-203. Lucking AJ, Gibson KR, Paterson EE, Faratian D, Ludlam CA, Boon NA, Fox KA, Newby DE (2013) Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis. Arteriosclerosis, thrombosis, and vascular biology 33:1105-1111. Macedo B, Batista AR, do Amaral JB, Saraiva MJ (2007) Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy. Molecular medicine 13:584-591. Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJ, Ward JD (1993) Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 36:454-459. Malik RA, Veves A, Masson EA, Sharma AK, Ah-See AK, Schady W, Lye RH, Boulton AJ (1992) Endoneurial capillary abnormalities in mild human diabetic neuropathy. Journal of neurology, neurosurgery, and psychiatry 55:557-561. Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, Boulton AJ (1998) Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 352:1978-1981. Mantovani A, Sica A, Allavena P, Garlanda C, Locati M (2009) Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Human immunology 70:325-330. Mathis S, Magy L, Diallo L, Boukhris S, Vallat JM (2012) Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. Muscle & nerve 45:26-31. Mazzeo A, Aguennouz M, Messina C, Vita G (2004) Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy. Archives of neurology 61:1097-1102. Melchor JP, Pawlak R, Strickland S (2003) The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. The Journal of neuroscience : the official journal of the Society for Neuroscience 23:8867-8871. Merkle DL, Cheng CH, Castellino FJ, Chibber BA (1996) Modulation of fibrin assembly and polymerization by the beta-amyloid of Alzheimer's disease. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 7:650-658. Misko A, Ferguson T, Notterpek L (2002) Matrix metalloproteinase mediated degradation of basement membrane proteins in Trembler J neuropathy nerves. Journal of neurochemistry 83:885-894. Mizisin AP, Weerasuriya A (2011) Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta neuropathologica 121:291-312. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC (1993) Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734-744. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nature reviews Immunology 8:958-969. Munar-Ques M, Pedrosa JL, Coelho T, Gusmao L, Seruca R, Amorim A, Sequeiros J (1999) Two pairs of proven monozygotic twins discordant for familial amyloid neuropathy (FAP) TTR Met 30. Journal of medical genetics 36:629-632. Nakamura Y, Yutani C, Nakazato M, Date Y, Baba T, Goto Y (1999) A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells. Pathology international 49:898-902. Nathan C, Shiloh MU (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proceedings of the National Academy of Sciences of the United States of America 97:8841-8848. Ogata J, Okayama M, Goto I, Inomata H, Yoshida I, Omae T (1978) Primary familial amyloidosis with vitreous opacities. Report of an autopsy case. Acta neuropathologica 42:67-70. Ohsawa K, Imai Y, Sasaki Y, Kohsaka S (2004) Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. Journal of neurochemistry 88:844-856. Owen WG, Esmon CT (1981) Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. The Journal of biological chemistry 256:5532-5535. Paul J, Strickland S, Melchor JP (2007) Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. The Journal of experimental medicine 204:1999-2008. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clinical and experimental immunology 142:481-489. Quintas A, Saraiva MJ, Brito RM (1999) The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis. The Journal of biological chemistry 274:32943-32949. Raz A, Shiratori T, Goodman DS (1970) Studies on the protein-protein and protein-ligand interactions involved in retinol transport in plasma. The Journal of biological chemistry 245:1903-1912. Rijken DC, Hoylaerts M, Collen D (1982) Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. The Journal of biological chemistry 257:2920-2925. Saito S, Ando Y, Nakamura M, Ueda M, Kim J, Ishima Y, Akaike T, Otagiri M (2005) Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis. Biochemistry 44:11122-11129. Song E, Ouyang N, Horbelt M, Antus B, Wang M, Exton MS (2000) Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cellular immunology 204:19-28. Sousa MM, Cardoso I, Fernandes R, Guimaraes A, Saraiva MJ (2001a) Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. The American journal of pathology 159:1993-2000. Sousa MM, do Amaral JB, Guimaraes A, Saraiva MJ (2005) Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 19:124-126. Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJ (2001b) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. The Journal of neuroscience : the official journal of the Society for Neuroscience 21:7576-7586. Sousa MM, Saraiva MJ (2003) Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Progress in neurobiology 71:385-400. Sousa MM, Yan SD, Stern D, Saraiva MJ (2000) Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Laboratory investigation; a journal of technical methods and pathology 80:1101-1110. Steffel J, Luscher TF, Tanner FC (2006) Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113:722-731. Stout RD, Suttles J (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. Journal of leukocyte biology 76:509-513. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U (2005) Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circulation research 96:1233-1239. Tabrizi P, Wang L, Seeds N, McComb JG, Yamada S, Griffin JH, Carmeliet P, Weiss MH, Zlokovic BV (1999) Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arteriosclerosis, thrombosis, and vascular biology 19:2801-2806. Takahashi R, Ono K, Ikeda T, Akagi A, Noto D, Nozaki I, Sakai K, Asakura H, Iwasa K, Yamada M (2012) Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 19:129-132. Teixeira AC, Saraiva MJ (2013) Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD. Journal of cellular and molecular medicine 17:429-435. Terazaki H, Ando Y, Fernandes R, Yamamura K, Maeda S, Saraiva MJ (2006) Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant. Laboratory investigation; a journal of technical methods and pathology 86:23-31. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS (2007) CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proceedings of the National Academy of Sciences of the United States of America 104:19446-19451. Vital C, Lagueny A, Mercie P, Viallard JF, Delabrousse-Mayoux JP, Vital A (2010) Usefulness of combined nerve and muscle biopsy in the diagnosis of amyloid neuropathy--a study of 6 new cases. Clinical neuropathology 29:59-64. Weisel JW (2005) Fibrinogen and fibrin. Advances in protein chemistry 70:247-299. Weiss HJ, Turitto VT, Baumgartner HR, Nemerson Y, Hoffmann T (1989) Evidence for the presence of tissue factor activity on subendothelium. Blood 73:968-975. Wilcox JN, Smith KM, Schwartz SM, Gordon D (1989) Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proceedings of the National Academy of Sciences of the United States of America 86:2839-2843. Yamamoto M, Kiyota T, Walsh SM, Liu J, Kipnis J, Ikezu T (2008) Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. Journal of immunology 181:3877-3886. Yamashita T, Ando Y, Katsuragi S, Nakamura M, Obayashi K, Haraoka K, Ueda M, Xuguo S, Okamoto S, Uchino M (2005) Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys. Muscle & nerve 31:41-45. Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, Yu J, Soto C, Schmidt AM, Stern D, Kindy M (2000) Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nature medicine 6:643-651. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62576 | - |
dc.description.abstract | 家族性類澱粉多發性神經病變(Familial amyloidotic polyneuropathy, FAP)是一種有甲狀腺素運送蛋白(transthyretin, TTR)沉澱形成類澱粉纖維堆積的疾病,主要又以周邊神經系統受影響。其症狀一開始和發炎性神經病變極為相似且組織切片上也有巨噬細胞浸潤,但是使用免疫抑制治療卻效果不彰,目前其神經退化之機制仍尚未明朗。本研究除了利用型態學的方法分析正常人(n=4)、糖尿病截肢(Diabetic amputation, DM)(n=13)、慢性脫髓鞘多發性神經炎(Chronic inflammatory demyelinating polyneuropathy, CIDP)(n=3)以及家族性類澱粉多發性神經病變患者(n=13)的有髓鞘神經纖維密度以及微血管病變因子,也利用免疫組織化學染色的方法觀察家族性類澱粉多發性神經病變之巨噬細胞浸潤和分型、纖維蛋白沉積及其相關因子。實驗發現雖然家族性類澱粉多發性神經病變的Iba1免疫反應和慢性脫髓鞘多發性神經炎一樣偏高(正常人:0.08±0.03 O.D., DM:1.46±1.09 O.D., CIDP:5.35±1.38 O.D., FAP:3.01±1.05 O.D.),但有髓鞘神經纖維密度卻喪失嚴重,並且和可能是血管引起的糖尿病病變的退化程度相似(正常人:7595±1718 fibers/mm2, DM:2599±1601 fibers/mm2, CIDP:5046±2462 fibers/mm2, FAP:1086±686.1 fibers/mm2)。此外,家族性類澱粉多發性神經病變和糖尿病病人皆可觀察到微血管管壁厚度增厚(正常人:2.8±0.4μm, DM:4.46±0.83μm , CIDP:2.77±0.32, FAP:4.4±0.8μm)且管腔面積較狹窄(正常人:15.2±5.1%, DM:4.4±1.4%, CIDP:13.2±4.5%, FAP:9.1±4.4%),並和有髓鞘神經密度和皆有顯著相關(p < 0.05)。在此疾病的血管中也有不等的纖維蛋白沉積於神經內膜微血管(37.24±29.50%)和神經外膜的血管中(37.42±16.92%),並且和有髓鞘神經纖維密度以及Iba1免疫反應呈正相關(p < 0.05),雖然凝血酶調節素表現量沒有差異但其中組織因子有上調並和纖維蛋白有正相關(p < 0.05),也觀察到組織型纖維蛋白溶酶原激活物也有下調的現象。進一步我們發現替代性活化巨噬細胞的標定CD206有免疫反應於神經內膜中。綜合以上結果,我們提供了家族性類澱粉多發性神經病變的神經內膜微血管病變與神經退化嚴重程度相關聯的型態學證據,了解纖維蛋白有被上調造成不正常堆積於管腔內,並且連結纖維蛋白和巨噬細胞彼此的關係,此外,也提供巨噬細胞作用於此疾病的新思維,希望有助於運用在臨床治療上。 | zh_TW |
dc.description.abstract | Familial amyloid polyneuropathy (FAP) is characterized by the extracellular deposition of transthyretin (TTR) aggregates which form amyloid fibrils, particularly in the peripheral nervous system. The mechanisms of nerve degeneration in FAP remain unclear. In the present study, we performed morphological and immunohistochemical analysis of sural nerve biopsies from 13 patients with FAP, 3 patients with chronic inflammatory demyelinating polyneuropathy (CIDP), 13 diabetic amputee and 4 control subjects. Although the infiltration pattern of Iba1(+) macrophages resembled that of CIDP, the density of myelinated fibers was markedly reduced in FAP. Narrowing of lumen area (p < 0.05) and thickened wall thickness (p < 0.05) were observed in FAP. In FAP patients, the severity of neuropathy was correlated with capillary wall thickness (p < 0.05) and percentage of lumen area (%) (p < 0.05)。The proportion of fibrin accumulated endoneurial vessels was positively correlated with myelinated fiber density (p < 0.05) and Iba1 expression (p < 0.05). We also examined the expression of tissue factor, thrombomodulin and tissue plasminogen activator (tPA) to investigate the activation of coagulation and fibrinolysis. The immunoreactivity of tissue factor was upregulated in the vessels and associated with fibrin deposition (p < 0.05). But there was no alternation in the thrombomodulin expression. The expression of tPA was almost absent in FAP nerves (p < 0.05). To identify the phenotype of the macrophage present in the endoneurium, immunohistochemistry of CD206 was performed, and it was up-regulated in FAP compared with control group. In conclusion, we provided structural and pathological evidence that vascular changes were related to the severity of nerve degeneration in FAP. Upregulation of coagulation cascade in FAP leading to fibrin deposition in the epineurial and endoneurial vessels was also observed. Moreover, we determined that the macrophage phenotype in the endoneurium which was classified as alternatively activated macrophage, which may offer new insight into the function of macrophages in FAP. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T16:04:48Z (GMT). No. of bitstreams: 1 ntu-102-R00446003-1.pdf: 2153172 bytes, checksum: 78d2b5cc37850ba167808d6d4c819555 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | Acknowledgments i
摘要 ii 目錄 1 圖目錄 2 表目錄 3 前言 4 方法 9 結果 14 討論 18 參考文獻 22 圖與表 31 | |
dc.language.iso | zh-TW | |
dc.title | 類澱粉神經病變之神經退化機制 | zh_TW |
dc.title | Mechanisms of nerve degeneration in amyloid neuropathy | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 謝侑霖(You-Lin Xie),江皓郁(Hao-Yu Jiang),曾拓榮(Ta-Rong Zeng),趙啟超(Qi-chao Zhao) | |
dc.subject.keyword | 家族性類澱粉多發性神經病變,神經退化,小血管病變,纖維蛋白,巨噬細胞, | zh_TW |
dc.subject.keyword | Familial amyloid polyneuropathy,nerve degeneration,microangiopathy,fibrin deposition,macrophage, | en |
dc.relation.page | 55 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-06-25 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 解剖學暨細胞生物學研究所 | zh_TW |
顯示於系所單位: | 解剖學暨細胞生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 2.1 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。